<DOC>
	<DOCNO>NCT02847208</DOCNO>
	<brief_summary>Little known gynaecological follow-up cervical screening Cystic Fibrosis ( CF ) . Only study describe contraceptive practice cohort CF woman . The investigator cross-sectional study cohort 155 CF woman attend Lyon adult centre . Women attend CF adult centre 2014 complete write questionnaire contraceptive choice , frequency gynaecological follow-up cervical screening . Other clinical data collect CF adult centre registry . One hundred twenty woman ( 100 % ) answer questionnaire , among two post-menopausal ( 46 59 year age ) , five pregnant . Seventy-four per cent woman declare undergone gynaecological followup ( 89 % woman transplantation ) , 55 % report least one previous Pap smear test . Among transplanted patient , 58 % Papsmear test , despite immunosuppressive treatment . The overall rate contraception 64 % diabetic woman , 61 % . Among contraception user ; 65 % use oral contraception , predominantly combine estrogen-progestagen ( 47 % ) ; among diabetic patient , 26 % use progestin-only contraception . Intrauterine device account 10 % patient use contraception , tubal ligation 4 % . This study limit cross-sectional design . Despite internal validation questionnaire show almost perfect agreement , risk recall bias take account . This study practice highlight importance improve information regard sexuality , fertility reproductive health young woman CF . A regular gynaecological follow-up cervical screen mandatory population . Better gynaecological care contraceptive advice would help avoid unplanned pregnancy , optimize contraceptive selection relationship specific clinical condition .</brief_summary>
	<brief_title>Contraceptive Practices Cervical Screening Women With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>woman cystic fibrosis follow Lyon adult centre 2014 No exclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>contraception</keyword>
	<keyword>gynaecological follow-up</keyword>
	<keyword>screen</keyword>
	<keyword>Pap smear</keyword>
	<keyword>counsel</keyword>
</DOC>